1. Agid, Y., Pollak, P., Bonnet, A. M., Signoret, J. L., Lhermitte, F.: Bromocriptine associated with a peripheral dopamine blocking agent in treatment of Parkinson's Disease. Lanceti, 570?572 (1979).
2. Brücke, T., Danielczyk, W., Simanyi, M., Riederer, P.: First clinical results with the partial dopamine agonist terguride: study in 15 parkinsonian patients. In: VIII International Symposium on Parkinson's Disease, New York, 1985, p. 109.
3. Corsini, G. U., Del Zompo, M., Gessa, G. L., Mangoni, A.: Therapeutic efficacy of apomorphine combined with an extracerebral inhibitor of dopamine receptors in Parkinson's disease. Lanceti, 854?855 (1979).
4. Dorow, R., Breitkopf, M., Graf, K. J., Horowski, R.: Neuroendocrine effects of lisuride and its 9, 10-dihydrogenated analog in healthy volunteers. In: Lisuride and Other Dopamine Agonists (Calm, D. B., Horowski, R., McDonald, R.J., Wuttke, W., eds.), pp. 161?174. New York: Raven Press. 1983.
5. Graf, K. J., Dorow, R.: Size reduction of a macroprolactinoma by the dopamine partial agonist terguride. In: XXIX Symposium of the German Society of Endocrinology, Göttingen, February 20?23, 1985.